ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Elanco Animal Health Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.49−0.06 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $11.88B
- P/E (TTM)
- –
- Dividend yield
- –
Elanco Animal Health Inc revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Farm Animal: | $2.51B | $2.46B | $2.36B | $2.29B | $2.23B | $2.24B | $2.25B | $2.29B | $2.32B | $2.25B | $2.27B | $2.21B | 50.0% | +12.5% |
| Pet Health | $2.45B | $2.38B | $2.30B | $2.25B | $2.20B | $2.14B | $2.14B | $2.12B | $2.13B | $2.07B | $2.10B | $2.11B | 48.8% | +11.2% |
| Cattle | $1.21B | $1.17B | $1.13B | $1.08B | $1.05B | $1.04B | $1.01B | $1.00B | $992.00M | $945.00M | $949.00M | $922.00M | 24.2% | +16.1% |
| Poultry | $907.00M | $899.00M | $858.00M | $834.00M | $805.00M | $788.00M | $796.00M | $803.00M | $799.00M | $779.00M | $765.00M | $732.00M | 18.1% | +12.7% |
| Swine | $387.00M | $390.00M | $379.00M | $376.00M | $377.00M | $367.00M | $366.00M | $360.00M | $365.00M | $364.00M | $382.00M | $384.00M | 7.7% | +2.7% |
| Contract Manufacturing and Other | $62.00M | $60.00M | $53.00M | $49.00M | $52.00M | $48.00M | $46.00M | $44.00M | $42.00M | $43.00M | $42.00M | $46.00M | 1.2% | +19.2% |
| Aqua | – | – | $0 | $0 | $1.00M | $50.00M | $81.00M | $124.00M | $165.00M | $166.00M | $175.00M | $175.00M | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | $2.67B | $2.61B | $2.48B | $2.42B | $2.38B | $2.37B | $2.40B | $2.43B | $2.48B | $2.39B | $2.43B | $2.42B | 53.1% | +12.2% |
| United States | $2.36B | $2.29B | $2.23B | $2.17B | $2.11B | $2.06B | $2.04B | $2.02B | $2.01B | $1.97B | $1.98B | $1.95B | 46.9% | +11.7% |
From the segment and revenue-disaggregation notes of Elanco Animal Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.